Michael D West insider trades: AgeX Therapeutics (AGE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 10, 2018 | AGE | ↑ Buy | 4,000 | $3.86 | $15K | Direct | Dec 12, 2018 (2d) |
| Aug 22, 2017 | BTX | ↑ Buy | 2,000 | $2.60 | $5K | Direct | Aug 23, 2017 (1d) |
| Jul 22, 2014 | BTX | ↓ Sell | 270,000 | $2.65 | $716K | Direct | Jul 23, 2014 (1d) |
| May 31, 2012 | BTX | ↑ Buy | 10,000 | $4.05 | $40K | Direct | May 31, 2012 (0d) |
| Jun 22, 2011 | BTX | ↑ Buy | 10,000 | $4.40 | $44K | Direct | Jun 23, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael D West's insider trades
Michael D West is Chief Executive Officer at AgeX Therapeutics (AGE). Since Jun 22, 2011, Michael has reported 4 open-market purchases worth $105K and 1 sale worth $716K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (25 filings), shares withheld for taxes (21 filings), grants and awards (10 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.